NKTR

Nektar Therapeutics (NKTR)

About Nektar Therapeutics (NKTR)

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Details

Daily high

$54.20

Daily low

$52.01

Price at open

$54.01

52 Week High

$66.92

52 Week Low

$6.48

Market cap

1.1B

Dividend yield

0.00%

Volume

576,287

Avg. volume

611,148

P/E ratio

-6.89

Nektar Therapeutics News